abbvie glp-1 receptor agonist weight management diabetes treatments Pharmacology Consult: agonists for loss Glucagon-Like Peptide-1 Based Therapies: A
Description
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
The most consistent lipid change observed with GLP-1 therapy is a reduction in triglycerides , typically ranging from 10-20% in clinical studies
Libyan J Med 2014:9 online
Acute pancreatitis was reported in the liraglutide group
Cotadutide is safe with the most common side effects being mild to moderate nausea and vomiting, but with no greater severity or frequency than found in GLP-1 agonists [44]
The gut microbiota influences skeletal muscle mass and function in mice
